Results 231 to 240 of about 146,762 (298)

Factors mediating and associated with immunological response in women living with HIV in Sweden: A nationwide register‐based study

open access: yesHIV Medicine, EarlyView.
Abstract Introduction Women remain underrepresented in studies on immunological response (IR) among virally suppressed people living with HIV. Despite receiving antiretroviral therapy (ART) some individuals do not attain an IR, increasing their risk of non‐AIDS morbidity and mortality.
Josefin Nilsson   +6 more
wiley   +1 more source

Weight loss with real-world doravirine use in the OPERA cohort: a US-based cohort study. [PDF]

open access: yesAIDS Res Ther
Mounzer K   +7 more
europepmc   +1 more source

Effectiveness of switching to doravirine‐based antiretroviral therapy: A real‐world study in Germany

open access: yesHIV Medicine, EarlyView.
Abstract Objectives Doravirine (DOR)‐based antiretroviral therapy (ART) has been shown in clinical trials to be effective and well tolerated in treating HIV‐1. The EffectiVeness of SwItChing to DORavirine‐based Antiretroviral Therapy (VICDOR) study characterized the use, effectiveness and impact on body weight and lipids of DOR‐based ART in a ...
Christoph Wyen   +12 more
wiley   +1 more source

NME2 modulates HCC progression through 4EBP1 phosphorylation and autophagy regulation independent of mTOR. [PDF]

open access: yesHepatol Commun
Chen W   +9 more
europepmc   +1 more source

Retention outcomes during same‐day antiretroviral therapy initiation in health facilities and outreach settings of Rakai, Uganda, 2016–2021

open access: yesHIV Medicine, EarlyView.
Abstract Introduction The antiretroviral therapy (ART) initiation policy in Uganda recommends that ART is initiated on the same day of HIV diagnosis to those who do not have contraindications. We assessed determinants of retention in ART care at the first follow‐up (FFU) after same‐day ART initiation and retention in long‐term care beyond the FFU visit.
Jesca Basiima   +15 more
wiley   +1 more source

Lymphocyte Transformation Tests and Patch Tests to Identify Drugs Potentially Associated With Bullous Pemphigoid Development

open access: yesInternational Journal of Dermatology, EarlyView.
ABSTRACT Background Bullous pemphigoid (BP) is the most common autoimmune blistering disease, with a rising incidence in the elderly. BP is associated with multiple triggering factors, including drug exposure. However, evidence in this respect is limited, and the underlying immune mechanisms remain unknown.
Belen de Nicolas‐Ruanes   +17 more
wiley   +1 more source

Improved nucleoside (2’-deoxy)ribosyltransferases maximize enzyme promiscuity while maintaining catalytic efficiency

open access: yes
Tang P(   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy